- Home
- Publications
- Publication Search
- Publication Details
Title
Theranostic Advances in Breast Cancer in Nuclear Medicine
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 9, Pages 4597
Publisher
MDPI AG
Online
2021-04-28
DOI
10.3390/ijms22094597
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Construction of 124I-trastuzumab for noninvasive PET imaging of HER2 expression: from patient-derived xenograft models to gastric cancer patients
- (2020) Xiaoyi Guo et al. Gastric Cancer
- The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract – first clinical experience
- (2020) Stefan A. Koerber et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of 68Ga-FAPI and 18F-FDG PET/CT in a Patient With Cholangiocellular Carcinoma
- (2020) Yizhen Pang et al. CLINICAL NUCLEAR MEDICINE
- Theranostic approaches in nuclear medicine: current status and future prospects
- (2020) Luca Filippi et al. Expert Review of Medical Devices
- Radiopharmaceuticals for Breast Cancer and Neuroendocrine Tumors: Two Examples of How Tissue Characterization May Influence the Choice of Therapy
- (2020) Alberto Signore et al. Cancers
- Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine
- (2020) Christopher Montemagno et al. Cancers
- PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand Therapy
- (2020) Wallace Jones et al. Cancers
- Prostate-specific membrane antigen theranostics in advanced prostate cancer: an evolving option
- (2020) Nikhil Mayor et al. BJU INTERNATIONAL
- A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy
- (2020) Sanjana Ballal et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Fibroblast activation protein targeted PET/CT with 68Ga-FAPI for imaging IgG4-related disease: comparison to 18F-FDG PET/CT
- (2020) Yaping Luo et al. JOURNAL OF NUCLEAR MEDICINE
- Radiopharmaceutical therapy in cancer: clinical advances and challenges
- (2020) George Sgouros et al. NATURE REVIEWS DRUG DISCOVERY
- Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges
- (2020) Julie Refardt et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
- (2020) Paul Hoppenz et al. Frontiers in Chemistry
- Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine
- (2020) Sudath Hapuarachchige et al. Frontiers in Oncology
- Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic Review
- (2020) Paul Windisch et al. Cancers
- Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells
- (2019) Sayem Miah et al. BMC CANCER
- Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples
- (2019) Clément Morgat et al. PLoS One
- Development of novel FAP-targeted radiotracers with improved tumor retention
- (2019) Anastasia Loktev et al. JOURNAL OF NUCLEAR MEDICINE
- FAPI-PET/CT: Mean intensity of tracer-uptake (SUV) in 28 different kinds of cancer
- (2019) Clemens Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine
- (2019) Thomas Langbein et al. JOURNAL OF NUCLEAR MEDICINE
- Historical review of pharmacological development and dosimetry of PSMA-based theranostics for prostate cancer
- (2019) Nasim Vahidfar et al. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
- Copper-64 trastuzumab PET imaging: a reproducibility study
- (2019) Jorge A. Carrasquillo et al. The quarterly journal of nuclear medicine and molecular imaging
- The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
- (2019) Lea Monteran et al. Frontiers in Immunology
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Breast Cancer Imaging With PET Based Radiopharmaceuticals Other Than 18F-FDG
- (2019) Rakhee Vatsa et al. CLINICAL NUCLEAR MEDICINE
- In vitro cytotoxicity of Auger electron-emitting [67Ga]Ga-trastuzumab
- (2019) Muhamad Faiz bin Othman et al. NUCLEAR MEDICINE AND BIOLOGY
- Theranostic radiopharmaceuticals: established agents in current use
- (2018) James R Ballinger BRITISH JOURNAL OF RADIOLOGY
- Development of quinoline based theranostic ligands for the targeting of fibroblast activation protein
- (2018) Thomas Lindner et al. JOURNAL OF NUCLEAR MEDICINE
- A new method for tumor imaging by targeting cancer associated fibroblasts
- (2018) Anastasia Loktev et al. JOURNAL OF NUCLEAR MEDICINE
- Radiotheranostics in Cancer Diagnosis and Management
- (2018) Hossein Jadvar et al. RADIOLOGY
- Impact of Advancing Technology on Diagnosis and Treatment of Breast Cancer
- (2018) Heather I. Greenwood et al. SURGICAL CLINICS OF NORTH AMERICA
- PSMA Theranostics: Current Status and Future Directions
- (2018) Kambiz Rahbar et al. Molecular Imaging
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 68Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer
- (2018) Jie Zang et al. CLINICAL NUCLEAR MEDICINE
- 89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
- (2018) Frederike Bensch et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- FAPI-PET/CT: biodistribution and preliminary dosimetry estimate of two DOTA-containing FAP-targeting agents in patients with various cancers
- (2018) Frederik Giesel et al. JOURNAL OF NUCLEAR MEDICINE
- 111 In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible during Trastuzumab Treatment
- (2018) Sietske B.M. Gaykema et al. Molecular Imaging
- Theranostics and precision medicine special feature
- (2018) Shaunak Navalkissoor et al. BRITISH JOURNAL OF RADIOLOGY
- Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer
- (2017) Matti Annala et al. EUROPEAN UROLOGY
- Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors
- (2017) Clément Morgat et al. JOURNAL OF NUCLEAR MEDICINE
- Targeted radionuclide therapy in combined-modality regimens
- (2017) Martin R Gill et al. LANCET ONCOLOGY
- Molecular Breast Imaging in Breast Cancer Screening and Problem Solving
- (2017) Robin B. Shermis et al. RADIOGRAPHICS
- Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study
- (2017) Qi Wu et al. Oncotarget
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment
- (2016) Paola Moreno et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Development of Lu-177-trastuzumab for radioimmunotherapy of HER2 expressing breast cancer and its feasibility assessment in breast cancer patients
- (2016) Priya Bhusari et al. INTERNATIONAL JOURNAL OF CANCER
- Improved radiopharmaceutical based on 99mTc-Bombesin–folate for breast tumour imaging
- (2016) Liliana Aranda-Lara et al. NUCLEAR MEDICINE COMMUNICATIONS
- Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis
- (2016) Jiayuan Wu et al. Oncotarget
- Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist 68Ga-RM2 And PET
- (2016) Christian Stoykow et al. Theranostics
- Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer
- (2016) Byeong-Cheol Ahn Biomed Research International
- Evaluation and comparison of a new DOTA and DTPA - bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models
- (2015) Priscilla B. Pujatti et al. APPLIED RADIATION AND ISOTOPES
- In Vitro and In Vivo Application of Radiolabeled Gastrin-Releasing Peptide Receptor Ligands in Breast Cancer
- (2015) S. U. Dalm et al. JOURNAL OF NUCLEAR MEDICINE
- Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
- (2015) Alexandre Calon et al. NATURE GENETICS
- Insights into bombesin receptors and ligands: Highlighting recent advances
- (2015) Irene Ramos-Álvarez et al. PEPTIDES
- GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI
- (2015) Fan Pu et al. Scientific Reports
- An Exploratory Study on 99mTc-RGD-BBN Peptide Scintimammography in the Assessment of Breast Malignant Lesions Compared to 99mTc-3P4-RGD2
- (2015) Qianqian Chen et al. PLoS One
- Visualization and body distribution of [131I]-herceptin in nude mice with BT-474 breast carcinoma
- (2014) Z.X. Yang et al. GENETICS AND MOLECULAR RESEARCH
- Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)
- (2014) Koen Jansen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Preserved Coronary Flow Reserve Effectively Excludes High-Risk Coronary Artery Disease on Angiography
- (2014) M. Naya et al. JOURNAL OF NUCLEAR MEDICINE
- The chemistry, physiology and pathology of pH in cancer
- (2014) P. Swietach et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Prognostic relevance of cancer-associated fibroblasts in human cancer
- (2014) Janna Paulsson et al. SEMINARS IN CANCER BIOLOGY
- Comparative Effectiveness of Digital Versus Film-Screen Mammography in Community Practice in the United States
- (2013) Karla Kerlikowske ANNALS OF INTERNAL MEDICINE
- Theranostic and Molecular Classification of Breast Cancer
- (2013) Kristine M. Cornejo et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Pilot study of 68Ga-DOTA-F(ab′)2-trastuzumab in patients with breast cancer
- (2013) Volkan Beylergil et al. NUCLEAR MEDICINE COMMUNICATIONS
- The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial
- (2012) A. Huijbers et al. ANNALS OF ONCOLOGY
- Molecular Imaging Radiotherapy: Theranostics for Personalized Patient Management of Neuroendocrine Tumors (NETs)
- (2012) Kjell Öberg Theranostics
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- (2011) Dennis Slamon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
- (2010) E C Dijkers et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE
- (2010) Irene Virgolini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The epidermal growth factor receptor family in breast cancer
- (2010) Angelos Koutras OncoTargets and Therapy
- 18F,64Cu, and68Ga Labeled RGD-Bombesin Heterodimeric Peptides for PET Imaging of Breast Cancer
- (2009) Zhaofei Liu et al. BIOCONJUGATE CHEMISTRY
- Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women
- (2009) Clara L. Santos-Cuevas et al. NUCLEAR MEDICINE COMMUNICATIONS
- Prognostic factors in 1038 women with metastatic breast cancer
- (2008) R. Largillier et al. ANNALS OF ONCOLOGY
- Gastrin-Releasing Peptide Receptor Imaging in Human Breast Carcinoma Versus Immunohistochemistry
- (2008) C. Van de Wiele et al. JOURNAL OF NUCLEAR MEDICINE
- International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States
- (2008) R. T. Jensen et al. PHARMACOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started